The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure

Conditions:   COVID-19;   Hypoxemic Respiratory Failure Intervention:   Device: High flow nasal oxygen (HFNO, more than 15 L/min) Sponsor:   Amsterdam UMC, location VUmc Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials